Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 407 (RNA5SP407) is a processed pseudogene related to the family of 5S ribosomal RNA genes. Pseudogenes like RNA5SP407 are DNA sequences that resemble functional genes but have lost their gene expression capability due to mutation, truncation, or integration into non-genic genomic regions[4]. The canonical 5S ribosomal RNA (from which the nomenclature derives) is a 120-nucleotide structural RNA critical to the large ribosomal subunit assembly and function in all domains of life except certain mitochondrial ribosomes[1][3][7]. However, RNA5SP407 itself does not produce a functional RNA or protein: it is non-coding and lacks the regulatory elements to be transcribed as active 5S rRNA[4][2]. While the general class of pseudogenes may influence gene regulatory networks or serve as disease markers because of their transcriptional activity or sequence similarity to coding genes[6], current databases and literature provide no evidence for any direct biological or therapeutic relevance, functional product, or druggability of RNA5SP407. Its main value lies in genomic annotation, evolutionary studies, and the broad, theoretical discussion of pseudogene function[4][6]. Key points: - RNA5SP407 is not a therapeutic target, receptor, enzyme, transporter, or transcription factor. - It is not associated with pharmacological agents and does not have a defined molecular or clinical function. - Its status as a pseudogene means it is a non-functional genetic element derived from functional 5S rRNA genes. Note: This entry is "incorrect" as a druggable or biological target; it is a pseudogene with no current known function in cell biology or disease beyond putative regulatory roles assigned to the broader class of pseudogenes[4][6][2].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 407 (RNA5SP407).